How to Diagnose Asthma and COPD: A Simple Guide
Diagnosing Asthma
To diagnose asthma, you need to confirm episodic airway obstruction that reverses with bronchodilators using spirometry—specifically, an increase in FEV1 of >200 mL AND >12% from baseline after inhaling a short-acting beta-agonist. 1
Step-by-Step Approach for Asthma:
1. Look for These Key Symptoms:
- Cough (especially worse at night)
- Recurrent wheezing
- Recurrent shortness of breath
- Recurrent chest tightness
- Symptoms that get worse with: exercise, viral infections, allergens (pets, dust mites, mold, pollen), irritants (smoke, chemicals), weather changes, strong emotions, stress, or menstrual cycles
- Nighttime symptoms that wake the patient 1
2. Do Spirometry (Required—Not Optional):
- Spirometry is essential because history and physical exam alone are unreliable 1
- Perform baseline spirometry, then give a short-acting bronchodilator
- Asthma is confirmed if FEV1 increases by BOTH >200 mL AND >12% from baseline 1
- Some evidence suggests >10% of predicted FEV1 improvement may better separate asthma from COPD 1
- Don't use peak flow meters for diagnosis—they're for monitoring only due to high variability 1
3. If Spirometry is Normal but You Still Suspect Asthma:
- Consider bronchoprovocation testing with methacholine, histamine, cold air, or exercise challenge
- A positive test confirms airway hyperresponsiveness (characteristic of asthma)
- A negative test is more useful—it essentially rules out asthma 1
4. Physical Exam Findings (May Be Absent Between Episodes):
- Upper respiratory: increased nasal secretions, mucosal swelling, nasal polyps
- Chest: wheezing during normal breathing or prolonged forced exhalation, hyperexpansion, accessory muscle use, hunched shoulders
- Skin: atopic dermatitis, eczema 1
Common Pitfall: Don't diagnose "wheezy bronchitis" or "reactive airway disease" in young children—these are often asthma that needs proper treatment 1
Diagnosing COPD
To diagnose COPD, you need persistent airflow obstruction on post-bronchodilator spirometry—specifically, FEV1/FVC ratio <0.7 after bronchodilator administration—in someone with chronic respiratory symptoms and exposure to risk factors like smoking. 2
Step-by-Step Approach for COPD:
1. Identify Risk Factors and Symptoms:
- Smoking history >200 pack-years (cigarettes per day × years of smoking ÷ 20) is highly suggestive 3
- Biomass smoke exposure
- Productive cough (chronic)
- Exertional dyspnea
- Chronic sputum production 4
2. Do Spirometry (Required—Both Pre and Post-Bronchodilator):
- The 2025 GOLD guidelines recommend using pre-bronchodilator spirometry to rule out COPD and post-bronchodilator measurements to confirm the diagnosis 2
- Give a bronchodilator, then repeat spirometry
- COPD is confirmed if post-bronchodilator FEV1/FVC <0.7 2
- The obstruction should NOT be fully reversible (unlike asthma)
Why Both Pre and Post-BD Measurements Matter:
- Some patients are "volume responders"—they have gas trapping that makes pre-BD FEV1/FVC ≥0.7, but post-BD their FVC improves more than FEV1, dropping the ratio to <0.7 and revealing true COPD 2
- "Flow responders" may show pre-BD obstruction that appears to resolve post-BD (FEV1/FVC goes from <0.7 to ≥0.7), but these patients often develop persistent obstruction later and need monitoring 2
3. Additional Findings:
- Chest X-ray showing emphysema signs 3
- Maximal FEV1 <80% predicted even after treatment 3
- The obstruction is persistent and not fully reversible (this is the key difference from asthma) 4
4. What "Not Reversible" Means:
- Improvement in FEV1 <12% AND <200 mL after bronchodilator suggests COPD over asthma 4
- However, this criterion alone is only 55% sensitive and 81% specific, so it's not perfect 5
Key Differences to Remember:
| Feature | Asthma | COPD |
|---|---|---|
| Age of onset | Usually younger | Usually >40 years |
| Smoking history | Often <200 pack-years | Usually >200 pack-years [3] |
| Symptoms | Episodic, variable | Persistent, progressive |
| Reversibility | FEV1 improves >200 mL AND >12% | FEV1 improves <200 mL or <12% |
| Post-BD FEV1/FVC | May normalize | Remains <0.7 [2] |
What About Overlap?
Some patients have features of both diseases (asthma-COPD overlap). In these cases, spirometry shows reversibility (like asthma) but also persistent baseline airflow limitation (like COPD). 4 Treat these patients primarily following asthma guidelines, but add COPD-specific approaches as needed 4.
Critical Point: The current GOLD criteria (post-BD FEV1/FVC <0.7 plus FEV1 <80% predicted) are 100% sensitive but only 38% specific for COPD versus asthma 5. This means they catch all COPD cases but may misclassify some asthma patients as having COPD. When results are borderline, repeat testing to ensure accuracy 2.